1. Home
  2. GRDN vs RCUS Comparison

GRDN vs RCUS Comparison

Compare GRDN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$42.55

Market Cap

2.6B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$24.30

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
RCUS
Founded
2004
2015
Country
United States
United States
Employees
3600
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GRDN
RCUS
Price
$42.55
$24.30
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$40.60
$31.90
AVG Volume (30 Days)
349.0K
1.0M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.63
$45.62
P/E Ratio
$117.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.30
$7.92
52 Week High
$44.00
$28.72

Technical Indicators

Market Signals
Indicator
GRDN
RCUS
Relative Strength Index (RSI) 64.63 52.04
Support Level $31.74 $23.91
Resistance Level N/A $24.33
Average True Range (ATR) 1.57 1.45
MACD 0.18 0.04
Stochastic Oscillator 75.79 57.31

Price Performance

Historical Comparison
GRDN
RCUS

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: